Allogene Therapeutics, Inc.
ALLO
$1.23
-$0.06-4.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -27.24% | -34.82% | -37.37% | -9.62% | -18.33% |
| Total Receivables | 35.29% | 11.76% | 75.00% | 81.82% | -22.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.87% | 3.35% | 58.31% | 16.12% | 9.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -26.25% | -33.92% | -35.70% | -8.96% | -17.88% |
|
|
|||||
| Total Current Assets | -26.25% | -33.92% | -35.70% | -8.96% | -17.88% |
| Net Property, Plant & Equipment | -20.79% | -19.56% | -25.44% | -19.41% | -16.37% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 118.97% | 97.62% | 136.84% | 128.86% | -7.37% |
| Total Assets | -13.37% | -14.64% | -17.30% | -16.10% | -21.49% |
|
|
|||||
| Total Accounts Payable | -12.48% | -8.53% | -11.27% | 26.46% | -60.65% |
| Total Accrued Expenses | -4.23% | -1.97% | -20.07% | -54.73% | -52.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.12% | 10.83% | 12.33% | 13.16% | 11.97% |
| Total Finance Division Other Current Liabilities | -- | -55.83% | -- | -- | -68.50% |
| Total Other Current Liabilities | -- | -55.83% | -- | -- | -68.50% |
| Total Current Liabilities | -2.82% | -4.20% | -13.46% | -31.83% | -48.15% |
|
|
|||||
| Total Current Liabilities | -2.82% | -4.20% | -13.46% | -31.83% | -48.15% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.57% | -5.77% | -5.51% | -5.26% | -4.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 117.96% | 49.86% | 415.88% | 395.80% | 242.58% |
| Total Liabilities | -1.92% | -3.12% | -2.98% | -10.95% | -19.16% |
|
|
|||||
| Common Stock & APIC | 8.39% | 8.03% | 7.96% | 8.33% | 8.10% |
| Retained Earnings | -15.51% | -16.49% | -19.40% | -19.89% | -21.92% |
| Treasury Stock & Other | 104.64% | 90.68% | 106.51% | 79.75% | 84.38% |
| Total Common Equity | -16.47% | -17.58% | -20.47% | -17.32% | -22.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.47% | -17.58% | -20.47% | -17.32% | -22.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.47% | -17.58% | -20.47% | -17.32% | -22.10% |
|
|
|||||